4 AZA Bioscience Overview

  • Founded
  • 2002
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 2

4 AZA Bioscience General Information

Description

Developer of drugs targeting immune diseases, cancer and other life-threatening diseases. The company uses the biochemistry of pteridine and deazapteridine to identify immunomodulatory compounds. The company works in a unexplored area of chemical space which could give rise to new drugs.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Acquirer
Primary Office
  • Kapucijnenvoer 33
  • 3000 Leauven
  • Belgium
+32 016 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

4 AZA Bioscience Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore 4 AZA Bioscience‘s full profile, request access.

Request a free trial